Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, June 2005, p. 2367-2371, Vol. 49, No. 6
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.6.2367-2371.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Penetration of Linezolid into Soft Tissues of Healthy Volunteers after Single and Multiple Doses
Pejman Dehghanyar,1
Cornelia Bürger,2
Markus Zeitlinger,1
Florian Islinger,1
Florian Kovar,1
Markus Müller,1
Charlotte Kloft,2 and
Christian Joukhadar1,3*
Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Vienna, Austria,1
Department of Clinical Pharmacy, Freie Universität Berlin, Berlin, Germany,2
Department of Internal Medicine I, Division of Infectious Disease and Chemotherapy, Medical University of Vienna, Vienna, Austria3
Received 3 September 2004/
Returned for modification 31 December 2004/
Accepted 23 February 2005
The present study tested the ability of linezolid to penetrate soft tissues in healthy volunteers. Ten healthy volunteers were subjected to linezolid drug intake at a dose of 600 mg twice a day for 3 to 5 days. The first dose was administered intravenously. All following doses were self-administered orally. The tissue penetration of linezolid was assessed by use of in vivo microdialysis. In the single-dose experiments the ratios of the area under the concentration-time curve from 0 to 8 h (AUC0-8) for tissue to the AUC0-8 for free plasma were 1.4 ± 0.3 (mean ± standard deviation) and 1.3 ± 0.4 for subcutaneous adipose and muscle tissue, respectively. After multiple doses, the corresponding mean ratios were 0.9 ± 0.2 and 1.0 ± 0.5, respectively. The ratios of the AUC from 0 to 24 h (AUC0-24) for free linezolid in tissues to the MIC were between 50 and 100 for target pathogens with MICs between 2 and 4 mg/liter. In conclusion, the present study showed that linezolid penetrates rapidly into the interstitial space fluid of subcutaneous adipose and skeletal muscle tissues in healthy volunteers. On the basis of pharmacokinetic-pharmacodynamic calculations, we suggest that linezolid concentrations in soft tissues can be considered sufficient to inhibit the growth of many clinically relevant bacteria.
* Corresponding author. Mailing address: Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria. Phone: 43-1-40400/2981. Fax: 43-1-40400/2998. E-mail:
christian.joukhadar{at}meduniwien.ac.at.
Antimicrobial Agents and Chemotherapy, June 2005, p. 2367-2371, Vol. 49, No. 6
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.6.2367-2371.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Barbour, A., Schmidt, S., Sabarinath, S. N., Grant, M., Seubert, C., Skee, D., Murthy, B., Derendorf, H.
(2009). Soft-Tissue Penetration of Ceftobiprole in Healthy Volunteers Determined by In Vivo Microdialysis. Antimicrob. Agents Chemother.
53: 2773-2776
[Abstract]
[Full Text]
-
Kim, A., Suecof, L. A., Sutherland, C. A., Gao, L., Kuti, J. L., Nicolau, D. P.
(2008). In Vivo Microdialysis Study of the Penetration of Daptomycin into Soft Tissues in Diabetic versus Healthy Volunteers. Antimicrob. Agents Chemother.
52: 3941-3946
[Abstract]
[Full Text]
-
Schmidt, S., Banks, R., Kumar, V., Rand, K. H., Derendorf, H.
(2008). Clinical Microdialysis in Skin and Soft Tissues: An Update. J Clin Pharmacol
48: 351-364
[Abstract]
[Full Text]
-
Thallinger, C., Buerger, C., Plock, N., Kljucar, S., Wuenscher, S., Sauermann, R., Kloft, C., Joukhadar, C.
(2008). Effect of severity of sepsis on tissue concentrations of linezolid. J Antimicrob Chemother
61: 173-176
[Abstract]
[Full Text]
-
Stein, G. E., Schooley, S., Peloquin, C. A., Missavage, A., Havlichek, D. H.
(2007). Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. J Antimicrob Chemother
60: 819-823
[Abstract]
[Full Text]
-
Hayman, S., Wilson, A. P. R., Singer, M., Bellingan, G.
(2007). Effect of linezolid and teicoplanin on skin staphylococci. J Antimicrob Chemother
59: 1281-1282
[Full Text]
-
Ntziora, F., Falagas, M. E
(2007). Linezolid for the Treatment of Patients with Central Nervous System Infection. The Annals of Pharmacotherapy
41: 296-308
[Abstract]
[Full Text]
-
Buerger, C., Plock, N., Dehghanyar, P., Joukhadar, C., Kloft, C.
(2006). Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.. Antimicrob. Agents Chemother.
50: 2455-2463
[Abstract]
[Full Text]
-
Jones, R. N., Ross, J. E., Fritsche, T. R., Sader, H. S.
(2006). Oxazolidinone susceptibility patterns in 2004: report from the Zyvox(R) Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations. J Antimicrob Chemother
57: 279-287
[Abstract]
[Full Text]
-
Joukhadar, C., Dehghanyar, P., Traunmuller, F., Sauermann, R., Mayer-Helm, B., Georgopoulos, A., Muller, M.
(2005). Increase of Microcirculatory Blood Flow Enhances Penetration of Ciprofloxacin into Soft Tissue. Antimicrob. Agents Chemother.
49: 4149-4153
[Abstract]
[Full Text]